HTG2014-Section-Header-publications

Categories

Filter by Topics

ALK Apoptosis Asthma Autocrine Signaling B Cells benign Biofluid Biomarker Analysis Biomarker Discovery Biomarker Validation Biomarkers Bladder Cancer Breast Cancer Breast milk Cancer Genomics Cells Cerebrospinal Fluid Childhood Atopic Dermatitis Chronic Obstructive Pulmonary Disease Circulating miRNAs Colorectal cancer Comparative Study Comparison study computational toxicology Core Needle Biopsy COVID-19 Custom mRNA Cytokines Cytotoxic T Cells Dementia Diabetes Differential Expression Differential Gene Expression Analysis DLBCL Drug Response Drug Safety Drug Targets Drug-induced Liver Injury EGFR Muatations EMT epidemiology epigenomics Epstein-Barr Esophageal Cancer Exosomes Extracellular Vesicles Fabry Disease Feasibility FFPE FGF Ligand Trap Fibrous Tumors Gene Expression Profiling Gene Signature Analysis Glioblastoma Tumors Head and Neck Cancer Heart HTG EdgeSeq ALKPlus Assay EU HTG EdgeSeq Custom Assays HTG EdgeSeq DLBCL Cell of Origin Assay HTG EdgeSeq DLBCL-COO-CE-IVD HTG EdgeSeq Immune Response Panel HTG EdgeSeq Immuno-Oncology Assay HTG EdgeSeq miRNA Whole Transcriptome Assay HTG EdgeSeq miRNA Whole Transcriptome Panel HTG EdgeSeq Mouse mRNA Tumor Response Panel HTG EdgeSeq Oncology Biomarker Panel HTG EdgeSeq Path Assay HTG EdgeSeq Precision Immuno-Oncology Panel HTG EdgeSeq Precision Immunol-Oncology Panel HTG EdgeSeq System HTG EdgeSeq System Oncology Biomarker Panel HTG EdgSeq Immuno-Oncology Assay ibrutinib Immune Checkpoint Inhibitors Immune Related Genes Immune Response Immune Tolerance Immuno-Oncology immunohistochemistry IHC Immunotherapy Inflammation Juvenile Arthritis Kidney Liquid Biopsy Liver Lung Lung cancer Lymph Node Metastasis Lymphoma machine learning malignant Mechanism of Action Melanoma Mesothelioma Microenvironment MicroRNA miRNA Molecular Characterization Mouse mRNA custom mTOR pathway multi-omics Muscle Mutations NAFLD Nash and Fibrosis Neoantigens Neuroendocrine Tumor Neurologic Oncology Oral Cancer Osteoclast Ovarian cancer Pancreas Paralysis Pathogenesis Pathway Analysis Pathway analysis PCA Cell Lines PD-1 PD-L1 placenta Placenta Plasma predictive biology Predictive Biomarkers Predictive Modeling Progression free-survival Prostate Prostate Cancer qNPA Reproductive Response rate Reveal Rheumatoid Arthritis Risk Score Sarcoma Serum Signaling Inhibitors Signatures Sinonasal Carcinoma Skin SPECS Lung Consortium Squamous cell carcinoma Sub-typing surface plasmon Surveillance Survival Outcomes Synovial Fluid synthetic miRNA T-Cell T-cells Technology Comparison Therapeutic targets Thyroid Cancer TMB Toxicity Translational Medicine Treatment Outcome Tumor Biology Tumor Heterogeneity Tumor Microenvironment Urothelial carcinoma Uterus Wound healing Xenograft Tissue

2021

Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib

Balasubramanian, S., et al., Comparison of immunohistochemistry and gene expression profiling subtyping for diffuse large B-cell lymphoma in the phase III clinical trial of R-CHOP ± ibrutinib, British Journal of Haematology,  https://doi.org/10.1111/bjh.17450

View External Link

Page last updated September 16, 2021